🔎 Trials Near Me

Hjem › Multipelt myelom › New Mexico

Multipelt myelom kliniske forsøg i New Mexico

5 studier for Multipelt myelom søger deltagere på steder i New Mexico.

Officiel studietekst (engelsk)

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

  • Christus St. Vincent Regional Cancer Center, Santa Fe
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07518186

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

  • Christus St. Vincent Regional Cancer Center, Santa Fe
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT05552222

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • Lovelace Medical Center - Saint Joseph Square, Albuquerque
  • Presbyterian Kaseman Hospital, Albuquerque
  • The University of New Mexico Comprehensive Cancer Center, Albuquerque
  • og 2 flere
RekruttererFase 2
Alder 12 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT02693535

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

  • GSK Investigational Site, Farmington
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT07227311

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

  • Lovelace Medical Center-Saint Joseph Square, Albuquerque
  • University of New Mexico Cancer Center, Albuquerque
  • Presbyterian Kaseman Hospital, Albuquerque
  • og 1 flere
RekruttererFase 3
Alle aldre · Alle køn · Opdateret 10. jun. 2026 · NCT05561387

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.